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Summary
In most species, the meiotic cell cycle is arrested at the
transition between prophase and metaphase through
unclear somatic signals. Activation of the Cdc2-kinase
component of maturation promoting factor (MPF) trig-
gers germinal vesicle breakdown after the luteinizing
hormone (LH) surge and reentry into the meiotic cell
cycle [1–3]. Although high levels of cAMP and activa-
tion of protein kinase A (PKA) play a critical role in
maintaining an inactive Cdc2 [4–6], the steps down-
stream of PKA in the oocyte remain unknown. Using
a small-pool expression-screening strategy, we have
isolated several putative PKA substrates from a
mouse oocyte cDNA library. One of these clones en-
codes a Wee1-like kinase that prevents progesterone-
induced oocyte maturation when expressed in Xeno-
pus oocytes. Unlike the widely expressed Wee1 and
Myt1, mWee1B mRNA and its protein are expressed
only in oocytes, and mRNA downregulation by RNAi
injection in vitro or transgenic overexpression of
RNAi in vivo causes a leaky meiotic arrest. Ser15 resi-
due of mWee1B is the major PKA phosphorylation
site in vitro, and the inhibitory effects of the kinase
are enhanced when this residue is phosphorylated.
Thus, mWee1B is a key MPF inhibitory kinase in
mouse oocytes, functions downstream of PKA, and is
required for maintaining meiotic arrest.
Results and Discussion
mWee1b Isolation during a Small-Pool Expression
Screening for PKA Substrates
Although PKA involvement in the maintenance of mei-
otic arrest is widely accepted, it is unclear which PKA
substrates are phosphorylated/dephosphorylated dur-
ing reentry into the cell cycle. To isolate PKA substrates
involved in the control of meiotic maturation in mam-
malian oocytes and to understand the posttranslational
steps downstream of PKA, we carried out small-pool
expression screening of a mouse oocyte cDNA library
(see the Supplemental Experimental Procedures in the
Supplemental Data available with this article online).
One of the putative PKA substrates isolated by this
method codes for a Wee1 kinase homolog (mouse*Correspondence: marco.conti@stanford.eduWee1B, Figure S1, Supplemental Data) similar to a pre-
viously isolated clone from human cDNA libraries [7]. A
mobility shift of this protein was detected when in vitro-
translated [S35]-methionine-labeled mWee1B was incu-
bated with the PKA catalytic subunit (Figure 1A). Similar
to Xenopus Wee1, which prevents progesterone-induced
germinal vesicle breakdown (GVBD) by directly phos-
phorylating and inhibiting Cdc2 kinase [8, 9], ectopi-
cally expressed mWee1B also prevented Xenopus oo-
cyte GVBD induced by progesterone treatment in a
manner dependent on mRNA concentration Figure 1B).
In addition, the Cdc2 inhibitory phosphorylation (phos-
photyrosine 15) was not decreased by progesterone
treatment when mWee1B mRNA was overexpressed
(Figure 1C).
To define the role of mWee1B kinase activity in pre-
venting GVBD, we mutated the lysine residue involved
in adenosine triphosphate (ATP) binding in several of
the known Wee1-family kinases (K237 in Figure S1A) to
methionine [9], and we injected the mRNA of this mu-
tant into Xenopus oocytes. The inhibitory effect on pro-
gesterone-induced Xenopus oocyte maturation could
no longer be detected with this kinase-dead mutant
(Figure 1D). These findings suggest that mWee1B may
be involved in the control of meiotic arrest in mamma-
lian oocytes.
Expression Patterns of Wee1B, Wee1, and Myt1:
mWee1B Is a Maternally Expressed Gene
The mammalian Wee1 kinase family, which inhibits CDK
activity by phosphorylation of two highly conserved
residues, Thr14 and Tyr15 of Cdc2 [10, 11], consists of
Wee1 [9, 12] and Myt1 kinases. Because the ortholog
XeWee1A protein does not accumulate in stage IV Xen-
opus oocytes [8, 9, 12, 13], Myt1 is considered a major
inhibitory kinase of Cdc2 in the Xenopus immature oo-
cyte and is required to maintain meiotic arrest. Although
the presence of Wee1 was detected in competent
mouse oocytes [14, 15], expression of Myt1 has not
been reported. To define the expression patterns of the
Wee1 kinase family in mouse tissues, we compared the
mRNA levels of Wee1, Wee1B, and Myt1 by northern-
blot analysis (Figure 2A). Mouse Wee1B was detected
only in the ovary, whereas Wee1 was expressed pre-
dominantly in the thymus, spleen, kidney, and at lower
levels in the ovary and other tissues. These findings
are consistent with the expression pattern of Xenopus
Wee1A kinase, which is present only in the ovary. The
cellular patterns of expression of Wee1 and mWee1B
mRNAs were further investigated by in situ hybridiza-
tion. Mouse Wee1B mRNA was detected only in the
oocytes at all developmental stages of the follicle in-
cluding primary, secondary, preantral, and antral folli-
cles with an increase in signal during development (Fig-
ures 2Bc, 2Bd, 2Bh, 2Bi, and 2Be). Conversely, Wee1
mRNA was detected only in early developmental stages
of oocyte maturation, and oocytes from antral follicles
displayed no signal above background (Figures 2Ba,
2B , 2B , and 2B ). Wee1 was also detected in the testisb f g
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1671Figure 1. Isolation and Characterization of a Clone Coding for a
Wee1-like Kinase
(A) PKA phosphorylation causes a mobility shift of the protein en-
coded by the mWee1B clone. Isolated mWee1B cDNA was trans-
lated in vitro with [35S] methionine, and the reaction mixture was
incubated with (+) or without (−) a PKA catalytic subunit. The sam-
ples were then subjected to SDS-PAGE with 8% SDS-PAGE gel,
and bands were detected by autoradiography. The migrations of
protein size markers are shown on the left (kDa).
(B) Mouse Wee1B inhibits progesterone-induced GVBD in Xenopus
oocytes. Indicated amounts of in vitro-synthesized V5-tagged-
mWee1B mRNA (for W10, 10 ng mRNA; for W2, 2 ng mRNA) or
H2O were injected in stage IV Xenopus oocytes. Sixteen hours after
injection, oocytes were treated with 500 nM progesterone (Prog) to
induce oocyte maturation. The percentage of GVBD was deter-
mined by scoring the oocytes for a spot on the animal pole at dif-
ferent times after the addition of progesterone. The expression of
the mWee1B protein was confirmed by western-blot analysis with
a V5 antibody.
(C) Inhibition of GVBD by mWee1B is associated with maintenance
of Cdc2 phosphorylation. The Tyr 15 phosphorylation state of Cdc2
and the total amount of Cdc2 protein in the mWee1B-injected or
H2O-injected Xenopus oocytes was determined by western-blot
analysis with the phosphorylation-specific (pY15 Cdc2) or Cdc2 an-
tibodies 8 hr after progesterone treatment.
(D) The kinase activity of mWee1B is required for inhibition of pro-
gesterone-induced GVBD in Xenopus oocytes. Wild-type (WT) or
kinase-dead mutant (KinD) mWee1B mRNAs were injected into
Xenopus oocytes (10 ng/oocyte). After 16 hr incubation, oocytes
were treated with 500 nM progesterone to induce maturation. The
number of oocytes displaying a white spot on the animal pole was
scored at different times after the addition of progesterone. The
expression levels of tagged wild-type and mutated mWee1B pro-
teins were compared by western blot with the V5 antibody.by northern-blot analysis and in situ hybridization,
whereas mWee1B was not present (Figure 2A and Fig-
ure S2), unlike that reported in humans, where Wee1B
is expressed in the testis [7]. This suggests thatmWee1B does not play a role in mouse male meiosis.
Conversely, Myt1 mRNA was detected in most tissues
including the ovary and the testis, albeit at low levels
(Figure 2A and Figure S3). This restricted expression of
mWee1B was confirmed by RT-PCR with granulosa
cells and oocytes. Mouse Wee1B was detected only
in oocytes, whereas Wee1 and Myt1 were present in
granulosa cells (Figure 2C). Finally, mouse expressed
sequence tag (EST) database searches showed that
mWee1B sequences are retrieved only in cDNA pools
of ovary, GV oocytes, unfertilized eggs, and two-cell-
stage embryos. All these data strongly suggest that the
Wee1B gene is expressed exclusively in oocytes and
zygotes.
To determine the expression of mWee1B protein, we
produced a mouse Wee1B-specific antibody against
the C terminus of the protein (Figure S1A) and carried
out western-blot analysis with GV- and MII-stage mouse
oocytes. Mouse Wee1B protein was detected in GV-
and MII-stage oocytes (Figure 2Da). A second antibody
raised in rat also detected a protein of the correct size
in both transfected cells and oocytes (Figure 2Db).
Downregulation of mWee1B by RNAi Induces GVBD
in Mouse Oocytes
To probe the function of mWee1B during oocyte matu-
ration, a strategy of RNA interference was used to
downregulate mWee1 expression. If mWee1B were to
play an essential role in cAMP-mediated meiotic arrest,
downregulation of its expression would cause meiotic
resumption. A fusion construct of green fluorescence
protein (GFP) and hairpin dsRNA corresponding to the
amino terminus of the mWee1B sequence was gener-
ated [16]. This hairpin construct was injected into eggs
to generate transgenic mice, and nine female and two
male founders were obtained. Nine founders were used
to generate F1 females that were injected with pregnant
mare serum gonadotropins (PMSG) at 22–24 days of
age. Oocytes were collected in medium supplemented
with cilostamide (10 M), and maturation was scored
after 24 hr. In oocytes where PDE3A phosphodiesterase
is absent or is inhibited with the specific compound,
cilostamide, PKA activity is maintained at high levels
by the increased cAMP, thus preventing maturation in
vitro and in vivo [17]. Under this condition of meiotic
block, more than 25% of the oocytes collected from 12
transgenic females from nine founders were no longer
in GV and progressed to GVBD or polar-body extrusion
(Figures 3A and 3B) although differences were ob-
served among different founders (15%–35%). A de-
crease in the amount of endogenous mWee1B mRNA
was detected by RT-PCR (Figure 3C) and in situ hybrid-
ization (Figure S5). Together with the expression of GFP
protein, this finding documented that the hairpin was
successfully expressed in these oocytes (Figures 3Ac
and 3Af). Conversely, Myt1 mRNA expression was not
decreased in the knockdown oocytes. An assay of
pools of five oocytes randomly selected from the dif-
ferent groups confirmed an increase in Cdc2-kinase ac-
tivity after the knockdown of mWee1B (Figure 3D).
When mWee1B hairpin RNA was injected in vitro into
either wild-type oocytes maintained in meiotic arrest
with cilostamide or into PDE3A−/− mouse oocytes,
Current Biology
1672Figure 2. Expression of Wee1, Wee1B, and Myt1 in Mouse Tissues
(A) Northern-blot analysis of Wee1-kinase-family mRNA expression in mouse tissues. Mouse-tissue RNA blot was hybridized with the [32P]-
labeled mWee1B, Wee1, and Myt1 cDNA probes, respectively. Numbers at left refer to the migration of DNA standards (kb).
(B) In situ hybridization was performed with Wee1 (Ba, Bb, Bf, and Bg) and mWee1B (Bc, Bd, Bh, Bi, and Be) RNA in the mouse ovary section.
(Ba–e) are from PMSG-treated mouse ovaries (22 days old), and (Bf–i) are from 10-day-old immature mouse ovaries. Arrows mark the cytoplasm
of oocytes in the bright- and dark-field micrographs. Hybridization with sense RNAs produced no localized signal (data not shown). The
following magnifications were used: for (Ba–d), 200×; for (Bf–I), 40×; and for (Be), 600×.
(C) The expression of Wee1-kinase-family mRNAs was determined by RT-PCR in the mouse ovary and oocyte. Approximately 5 ng RNA from
granulosa cells (Gr) and total RNA from oocyte lysate corresponding to six oocytes (Oo) were used for RT-PCR. The sizes of the PCR products
are 480 bp for GAPDH, 380 bp for mWee1B, 300 bp for Wee1, and 270 bp for Myt1.
(D) Western-blot analysis of mWee1B protein in mouse oocytes. Transfected HEK293 cell lysate (1 g for blot a, 10 g for blot b) or total
oocyte lysate from mouse GV or MII oocytes (300 oocytes per lane) were prepared and fractionated on 8% SDS-PAGE. Gels were then
transferred to the PVDF membrane and probed with affinity-purified mWee1B antibodies raised in rabbits (Da) or rats (Db). The construct
transfected in HEK293 cells had an additional 45 amino acids compared to the native mWee1B as a result of V5 tagging at the C terminus.
Asterisks indicate possible phosphorylated forms of mWee1B in the MII stage of mouse oocytes.which remain arrested in the meiotic prophase even af-
ter isolation, approximately 30% resumed meiosis I and
extruded a polar body (Figure S4). These data suggest
that mWee1B acts downstream of PKA in maintaining
the blockade of oocyte maturation. Several contributing
factors may explain why downregulation of mWee1B
in vitro or in vivo does not produce meiotic maturation
in all oocytes. One possibility is that the RNAi produces
variable downregulation averaging a 50% reduction in
mWee1B mRNA and that the mWee1B protein has a
long half-life. Indeed, preliminary observations suggest
that mWee1B is more stable than Wee1 when ex-
pressed in frog oocytes (S.J.H., unpublished data). An-
other possibility is that the turnover of Tyr15 phosphor-
ylation is slow in oocytes in the absence of an active
Cdc25 phosphatase responsible for dephosphorylation
and activation of Cdc2. Thus, a decrease in the activity
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Bof the mWee1 kinase is reflected only in a partial de-rease in phosphorylation of Cdc2, unless Cdc25 is ac-
ivated at the same time. Indeed, if PKA phosphorylates
dc25 and promotes 14-3-3 binding, Cdc25 should be
argely inactive in PDE3A−/− oocytes. Finally, it is also
ossible that a loss of mWee1B activity is compen-
ated by the presence of Wee1 or Myt1 kinase. Wee1
inase immunoreactivity has been observed in mouse
ocytes, even though a decline has been reported in
ompetent oocytes [15], and Myt1 mRNA is detectable
n GV oocytes (Figure 2C). Little increase in Myt1 ex-
ression was detected in oocytes where mWee1B is
ownregulated (Figure 3C).
erine 15 of mWee1B Is a Major PKA Phosphorylation
ite, and PKA Phosphorylation Increases mWee1B
inase Activity
ecause of its isolation as a putative PKA substrate, wefurther investigated the possibility that PKA can directly
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(A) Oocytes from wild-type (Aa–c) or GFP/mWee1B/RNAi (Ad–f) mice
were collected in 10 M cilostamide and incubated for 24 hr. GVBD
progression and MII stage were scored by loss of GV and emission
of the polar body. Arrows indicate the polar body in the MII stage
oocytes. Oocytes were monitored for GFP expression with a fluo-
rescence microscope (Ab, Ac, Ae, and Af) to confirm the expression
of the RNAi construct.
(B) Percentage of GVBD and MII stage of oocytes from mWee1B
knockdown (KD) and wild-type (WT) mice. GVBD was detected by
disappearance of the germinal vesicle, and MII oocytes were
counted by extrusion of the polar body after 24 hr incubation with
10 M cilostamide. Numbers above the bars indicate the number
of the GVBD stage and of total isolated oocytes (p = 0.0061 with
paired t test).
(C) Decrease in the endogenous mWee1B mRNA levels in oocytes
from the mWee1B knockdown mice. RT-PCR was performed on
pools of six randomly selected oocytes from wild-type or mWee1B
knockdown mice with L19, mWee1B, and Myt1 specific primers
described in the Supplemental Experimental Procedures. A repre-
sentative experiment of the three performed is reported. Bars re-
port the average ratio of measurements ± standard error of the
mean (SEM) from three separate experiments.
(D) Activity of Cdc2 in wild-type and knockdown mice was mea-
sured after 24 hr incubation in cilostamide. The kinase assay fol-
lowed published procedures [16]. Each lane contains five randomly
selected oocytes from two wild-type and three knockdown mice.phosphorylate mWee1B. Recombinant tagged mWee1B
was expressed in HEK293 cells, immunoprecipitated with
V5 antibody, and incubated with catalytic subunit of PKA.
Mouse Wee1B was efficiently phosphorylated by the
PKA catalytic subunit (Figure 4A), and this phosphory-
lation was completely blocked by the PKA inhibitor,
H89 (Figure S6). Because Wee1 kinases possess auto-
phosphorylation activity [18], [32P] incorporation into
mWee1B was detected in wild-type mWee1B without
PKA addition (Figure 4A, lane 4). However, when a ki-
nase-dead mutant of mWee1B was used, the auto-
phosphorylation was abolished, but the PKA phosphor-
ylation was still evident (Figure 4A). Because a major
difference in [32P] incorporation was observed between
kinase-dead and wild-type mWee1B, we hypothesizedthat PKA phosphorylation enhances the autophosphor-
ylation of mWee1B. Indeed, when a phosphotyrosine-
specific antibody was used, an increase in mWee1B
tyrosine phosphorylation was observed in wild-type
mWee1B but not in the kinase-dead mutant (Figure
4A, middle panel). The PKA concentration required for
half-maximal phosphorylation of mWee1B (IC50) is 75
nM catalytic subunit (Figure S7A). Thus, it is likely that
most of mWee1B is phosphorylated in prophase-
arrested oocytes because half-maximal inhibition of
maturation by PKA occurs at a concentration of ap-
proximately 0.1 M [4].
In order to identify the PKA phosphorylation site of
mWee1B, we incubated several maltose binding pro-
tein (MBP) fusion proteins with PKA and [γ-32P]ATP. The
phosphorylation of the MBP 1–124 region (Figure 4B)
indicated that the N terminus of mWee1B contains the
major PKA phosphorylation site(s). Although two puta-
tive PKA consensus sequences at S15 and T170 were
identified, S15 is likely the major phosphorylation site
because the 124–546 fusion protein is not phosphory-
lated by PKA.
Even though it is distinct from the known consensus
14-3-3 binding sequence (RSXS) found in Xenopus and
mammalian Wee1, mWee1B displays a related sequence
at the C terminus (RGTSSV, Figure S1A), opening the
possibility of a PKA phosphorylation that is at the car-
boxyl terminus and promotes 14-3-3 binding. Indeed,
some minor PKA phosphorylation could be detected
with the C terminus of mWee1B (Figure 4B, 479–556).
This phosphorylation was not explored further because
we could not detect coimmunoprecipitation of 14-3-3
protein with unphosphorylated or phosphorylated
mWee1B when overexpressed in HEK293 cells (data
not shown). To confirm whether S15 is the major PKA
phosphorylation site, we generated GST-mWee1B fusion
proteins containing only the N terminus of mWee1B with
point mutations in the putative PKA phosphorylation
sites, and we performed an in vitro phosphorylation
(Figure 4C). A major decrease in [32P] incorporation was
observed after the mutation of S15 to alanine. A similar
result was obtained with a S15A mutant of full-length
mWee1B (Figure 4D).
The functional consequence of the phosphorylation
of S15 was determined by mRNA injection of the phos-
phorylation mutants of mWee1B in frog oocytes. When
the mRNA of the S15D mutant that mimics the phos-
phorylation state was injected into Xenopus oocytes,
this mutant inhibited progesterone-induced maturation
more efficiently than wild-type mWee1B (Figure 4E).
The 15D mutant-enhanced inhibition of oocyte GVBD is
due to direct phosphorylation and inhibition of Cdc2 ki-
nase (data not shown). Conversely, inhibition by the S15A
mutant did not differ from that of wild-type mWee1B, pos-
sibly because progesterone treatment causes a decrease
in PKA activity. That mWee1B activity is increased after
S15 phosphorylation was further demonstrated with a re-
constitution assay. Histone H1 phosphorylation by MII
oocyte extracts was determined after incubation with dif-
ferent mWee1B constructs. MII extracts contained de-
phosphorylated and therefore activated Cdc2/cyclinB
complex, which phosphorylates histone H1. The S15D
mutant inhibited H1 phosphorylation more potently
than wild-type mWee1B (Figure 4F). These results
strongly suggest that PKA phosphorylates S15 of
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1674Figure 4. Serine 15 of mWee1B Is Phosphor-
ylated Directly by PKA, and PKA Phosphory-
lation Increases mWee1B Activity
(A) Wild-type and a kinase-dead mutant of
mWee1B were transfected into HEK293 cells,
and immunoprecipitation was carried out
with IgG or V5 antibodies. The immune com-
plex was incubated with or without the PKA
catalytic subunit and 5 Ci [γ-32P]ATP for 30
min, and the phosphorylation state was de-
tected by SDS-PAGE and autoradiography.
The first and sixth lanes contain 10% of in-
put for immunoprecipitation to monitor the
expression of transfected genes. The tyrosine
residue phosphorylation of wild-type and the
kinase-dead form of mWee1B were mea-
sured by immunoblotting with phosphotyro-
sine-specific antibodies (PY20). The amounts
of loaded protein were determined by western
blot with V5 antibodies. A representative ex-
periment of the three performed is reported.
(B) Serine 15 of mWee1B is the major PKA
phosphorylation site. A schematic diagram
of full length mWee1B and the MBP-fused
truncated form is shown. Various MBP-con-
taining truncated forms of mWee1B were
generated and expressed in the bacterial
system. After purification by affinity chroma-
tography, purified fusion proteins were incu-
bated with PKA catalytic subunits in [γ-32P]
ATP for 10 min at 30°C. The radiolabeled fu-
sion proteins were detected by autoradio-
gram (Bb). The expression and purification of
MBP fusion proteins were monitored by
Coomassie-blue staining (Ba).
(C) GST-fusion mutants of the mWee1B N
terminus were generated and purified by af-
finity chromatography. The N terminus of
mWee1B (amino acid residue 1–207) was
constructed to GST fusion protein, and Ser-
ine 15 (15A) and threonine 170 (170A) sites
were mutated to alanine (15,170A for double
mutant). After purification, the fusion pro-
teins were incubated with the PKA catalytic
subunit and [γ-32P]ATP for 10 min at 30°C.
The radiolabeled fusion proteins were de-
tected by autoradiography (Ca), and the
amount of fusion protein and phosphoryla-
tion of fusion proteins also were confirmed by mobility shift in the western-blot analysis with GST antibodies (Cb).
(D) Phosphorylation of the wild-type and S15A mutant of mWee1B. Experimental conditions for expression of the mutant and in vitro phos-
phorylation are the same as those described in Figure 4A.
(E) Effect of Serine 15 mutants of mWee1B on progesterone-induced Xenopus oocyte maturation. Five nanograms of mRNA coding for wild-
type, S15A, and S15D mutants of mWee1B or H2O (vehicle) was injected into Xenopus oocytes. Twelve hours later, oocytes were treated with
500 nM of progesterone, and meiotic maturation was monitored up to 9 hr. The expression of injected mRNAs was detected by western blot
with V5 antibodies. This result is one representative experiment of seven separate experiments performed (p = 0.0002 with paired t test).
(F) Effect of Serine 15 mutant of mWee1B on Cdc2 kinase activity. The kinase assay was carried out with five MII-stage oocytes per lane as
a source of activated Cdc2/cyclinB. Immune complexes of wild-type and a S15D mutant of mWee1B were incubated with MII oocyte lysate
for 30 min, and incubation continued after the addition of Histone H1 and 5 Ci [γ-32P]ATP for an additional 30 min. After separation on 15%
SDS PAGE, the phosphorylation state and amounts of loaded protein were detected by autoradiography (upper panel) or western blot with
V5 antibodies (lower panel). A representative experiment of the four performed is reported. The bar graph reports the ratio of [32P] incorpora-
tion into Histone H1 and the amount of immune complexes (p = 0.0195 with paired t test).mWee1B, and this phosphorylation causes an increase
in mWee1 activity toward Cdc2/cyclinB with conse-
quent enhanced inhibitory effects on oocyte matura-
tion. PKA activation of Wee1B was difficult to detect in
this assay paradigm because PKA directly phosphory-
lates histone H1 and increases the background (data
not shown).
The most straightforward hypothesis on how cAMP
inhibits the MPF activity is that PKA directly phos-
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shorylates and regulates the Cdc25 phosphatase and
ee1/Myt1 kinase. In agreement with this view, it has
een reported that PKA phosphorylates and inhibits the
unction of Cdc25 through 14-3-3 binding in frog oo-
ytes [19], even though the timing of this phosphoryla-
ion is inconsistent with a decrease in PKA activity.
ere, we show that mWee1B is a substrate for PKA
n vitro and have identified the major phosphorylation
ite in S15; the site lies within a consensus sequence
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1675for PKA (KKLS). This region is conserved only partially
when human and frog sequences are compared. Rather
than the PKA consensus, a related sequence is present
in human and frog Wee1 orthologs and includes a posi-
tively charged R or K upstream of an S. Further experi-
ments are necessary to determine when dephosphory-
lation of mWee1B occurs and whether the regulation
observed in the mouse can be extended to other spe-
cies. There is precedence for Wee1 activation by phos-
phorylation. MAP kinase activates XeWee1A via phos-
phorylation during the first mitotic cell cycle, producing
a delay in G2/M [20]. However, the phosphorylation sites
and exact mechanisms leading to an increase in the
Wee1 kinase activity have not been elucidated. XeWee1A
also is positively regulated by Chk1-kinase-dependent
phosphorylation on the C terminus of XeWee1 [21].
Thus, in addition to phosphorylations that promote tar-
geting to the proteasome and Wee1 degradation [22],
there is an additional mode of Wee1-kinase regulation
controlling its activation. It is likely that multiple phos-
phorylations are required for fine regulation of the func-
tion of this kinase that is essential for G2/M transition.
Conclusions
With this report, we demonstrate that mWee1B is a ma-
ternally-expressed kinase involved in the phosphorylation
of Cdc2 and maintenance of meiotic arrest in oocytes.
Mouse Wee1B is exclusively expressed in maturing oo-
cytes, and downregulation of this mRNA causes meiotic
resumption under conditions that normally maintain mei-
otic arrest. Conversely, overexpression of mWee1B de-
lays meiotic maturation in Xenopus oocytes, and its ki-
nase activity is required for this inhibition. PKA directly
phosphorylates mWee1B in a concentration-dependent
manner, at least in vitro. Serine 15 in the N terminus
of mWee1B is a major PKA phosphorylation site, and
phosphorylation at this site enhances the autophos-
phorylation activity of mWee1B and its ability to inhibit
Cdc2 and oocyte maturation. Thus, mWee1B is likely
to be a key regulator of meiotic maturation in mouse
oocytes. In view of the expression of mWee1B during
MII, further experiments are necessary to explore its
function during the first embryonic divisions. These
findings solidify the concept that PKA maintains mei-
otic arrest via dual regulation of the kinase that phos-
phorylates Cdc2 and the phosphatase that dephos-
phorylates the same sites. The two limbs of the
regulatory loop most likely work in a synergistic fashion
to maintain an inactive Cdc2/cyclinB complex.
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Supplemental Data include Supplemental Results and Discussion,
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figures and are available with this article online at: http://www.
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